Beit Jala Pharmaceutical Co (XPAE:BJP) Probability of Financial Distress (%)

Beit Jala Pharmaceutical Co Probability of Financial Distress (%) Chart

Competitive Comparison of Beit Jala Pharmaceutical Co's Probability of Financial Distress (%)

For the Biotechnology subindustry, Beit Jala Pharmaceutical Co's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beit Jala Pharmaceutical Co's Probability of Financial Distress (%) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beit Jala Pharmaceutical Co's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Beit Jala Pharmaceutical Co's Probability of Financial Distress (%) falls into.

Beit Jala Pharmaceutical Co  (XPAE:BJP) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.

Beit Jala Pharmaceutical Co Probability of Financial Distress (%) Related Terms

Thank you for viewing the detailed overview of Beit Jala Pharmaceutical Co's Probability of Financial Distress (%) provided by GuruFocus.com. Please click on the following links to see related term pages.

Beit Jala Pharmaceutical Co Business Description